Hopman Mark sold BBNX
September 9, 2026 · Form 4 insider transaction
Hopman Mark sold 36,870 shares of Beta Bionics, Inc. at $18.46 per share, a transaction worth $680.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
36,870
Price
$18.46
Total value
$680.7K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 9, 2026
Filing dateSeptember 10, 2026
Shares owned after87,157
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.